Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-09-13
1986-08-05
Jiles, Henry R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546121, A61K 3144
Patent
active
046044000
ABSTRACT:
3-(N,N-Dimethylcarbamoyl)pyrazolo[1,5-a]pyridine of the formula: ##STR1## which is a new compound, possesses pharmacological properties, in particular properties which are indicative of outstanding utility in the treatment of arthritic disorders such as rheumatoid arthritis. The compound can be prepared by reacting a pyrazolo[1,5-a]pyridine-3-carbonyl halide (e.g. chloride) with dimethylamine.
REFERENCES:
Chemical Abstracts vol. 95, P115542g (1981).
Chemical Abstracts vol. 94, P180683x (1981).
Collins Raymond F.
Ramsden Christopher A.
Saunders Libert C.
Warne Peter J.
Dentz Bernard I.
Jiles Henry R.
May & Baker Limited
LandOfFree
Treating arthritis with 3-(N,N-dimethyl carbamoyl)pyrazolo[1,5-a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treating arthritis with 3-(N,N-dimethyl carbamoyl)pyrazolo[1,5-a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treating arthritis with 3-(N,N-dimethyl carbamoyl)pyrazolo[1,5-a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-969353